As previously reported in the Current Report on Form 8-K filed by TRxADE HEALTH, Inc. with the Securities and Exchange Commission (the Commission"), on March 3, 2023, Ms. Janet Huffman, the then Chief Financial Officer of the Company, effective March 1, 2023, transitioned from Chief Financial Officer to Acting Chief Financial Officer. On March 6, 2023, Ms. Huffman resigned as Principal Financial/Accounting Officer of the Company in order to transition to a full-time role with another employer, and not due to any disagreement relating to the Company's operations, policies or procedures, provided that Ms. Huffman will continue to provide consulting services to the Company. Also effective on March 6, 2023, Prashant Patel, a member of the Board of Directors, the President and the Chief Operating Officer of the Company, was appointed as Interim Principal Financial/Accounting Officer of the Company.

There are no family relationship between any director, executive officer, or person nominated or chosen by the Company to become a director or executive officer. Mr. Patel, age 48, has served as the company's full-time President and Chief Operating Officer, and as a director, since the company' acquisition of Trxade Group, Inc., a Nevada corporation (Trxade Nevada") in January 2014. Mr. Patel is a registered pharmacist and pharmaceutical consultant with over twenty years of experience in retail pharmacy and pharmaceutical logistics, and the founder of several pharmacies in the Tampa Bay, Florida area.

Mr. Patel has been President and a Member of the Board of Trxade Nevada since August 2010. Since January 9, 2014, Mr. Patel has served as President of Trxade, Inc. Since October 2008, Mr. Patel has been Managing Member of APAA LLC, a pharmacy and CEO of Pharmaceutical Returns Of America LLC. Mr. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, United Kingdom.